Financials
Financial year 2025
Revenue
€ 11.6 million
▲ 8% vs 2024
Profit
Growing€ 585,117
▲ 2% vs 2024
Debts
Low€ 2 million
▲ 44% vs 2024
ORIONIS BIOSCIENCES from Gent, company number BE0635962088, closed financial year 2025 with a result of € 585,117 after tax. For that financial year ORIONIS BIOSCIENCES recorded revenue of € 11.6 million and equity of € 4.9 million. Compared with financial year 2024, the result moved from € 572,619 to € 585,117. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
What happened at ORIONIS BIOSCIENCES?
What happened at ORIONIS BIOSCIENCES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 585,117 (▲ 2% vs 2024). Source: NBB ↗
- Anthony FADELL became a director. NBB
- Bihua CHEN became a director. NBB
- Nikolai KLEY became a director. NBB
- Steven GULLANS became a director. NBB
- Griet VAN POUCKE became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 514,424 profit in 2021 to € 585,117 profit in 2025.
Best year ever: 2022, with € 783,655 profit.
On average € 163,500 of value added per employee in 2025.
A new publication or filing at ORIONIS BIOSCIENCES? We notify you, reason included.
Follow ORIONIS BIOSCIENCESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ORIONIS BIOSCIENCES are Steven GULLANS, Nikolai KLEY, Anthony FADELL, Griet VAN POUCKE and Bihua CHEN.
Directors
According to the 2025 annual accounts
Steven GULLANS
Director
since 2019
Nikolai KLEY
Director
since 2020
Anthony FADELL
Director
since 2023
Griet VAN POUCKE
Director
since 2019
Bihua CHEN
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
S-Biomedic
€ 4.4 million gross margin · 2025
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
272BIO
€ 104,252 gross margin · 2025
+11 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
GO-DADDY-COM-LLC - GoDaddy.com, LLC, US
DNS
GoDaddy DNS
Domain
Domain
orionisbio.com
Registered
2015-04-01
Registrar
Squarespace Domains II LLC
Expires
2028-04-01
Website info
Features
Security
Details
- Company number
- 0635.962.088
- VAT number
- BE 0635.962.088
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- ORIONIS BIOSCIENCES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 September 2015
- Peppol
- Active · Active since 19 Jun 2025
- Contact
- orionisbio.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied